Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine 5% Plaster vs Systemic Treatment in PHN and DPN
NCT00414349Phase 3Completed
- Sponsor
- Grünenthal GmbH
- Start
- Dec 2006
- Primary completion
- Jan 2008
- Countries
- 1
01
Overview
A Phase 3 trial of lidocaine 10% oropharyngeal spray in postherpetic neuralgia (PHN), diabetic polyneuropathy (DPN), sponsored by Grünenthal GmbH. Started Dec 2006; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
postherpetic neuralgia (PHN)diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NCT00414349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00414349.